Keloidal scars: A review with a critical look at therapeutic options

Journal of the American Academy of Dermatology

Volumn 46, Issue 2 III, 2002, Pages

  Shaffer, Joseph J ^a,b   Taylor, Susan C ^a,b   Cook Bolden, Fran ^a,b  

^a St Luke's Roosevelt Hospital ^*

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CORTICOSTEROID; CYTOKINE; FLUOROURACIL; GROWTH FACTOR; HYALURONIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON; SILICONE GEL; TRIAMCINOLONE ACETONIDE; TRANSFORMING GROWTH FACTOR BETA;

CARBOHYDRATE SYNTHESIS; CARBON DIOXIDE LASER; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CRYOTHERAPY; DRUG EFFICACY; FOLLOW UP; HEADACHE; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; HYPOPIGMENTATION; HYPOXIA; IMMUNE RESPONSE; INTERMETHOD COMPARISON; KELOID; MONOTHERAPY; MYALGIA; NEODYMIUM LASER; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSED DYE LASER; RACE DIFFERENCE; REVIEW; SKIN SURGERY; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; WOUND DRESSING; WOUND HEALING; DIFFERENTIAL DIAGNOSIS; INJURY; METABOLISM; PHYSIOLOGY; SKIN;

CICATRIX, HYPERTROPHIC; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; HUMANS; KELOID; SKIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 17444374137     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120788     Document Type: Article

References (167)

1. Alibert JLM. Description des malasies de la peau observees a l'hopital Saint-Louis et exposition des meilleures methods suives pour leur traitment. Paris: Barrois l'aine et fils; 1806. p. 113.
2. Urioste SS, Arndt KA, Dover JS. Keloidal scars and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 1999;18:159-71.
3. Muir IFK. On the nature of keloidal scars and hypertrophic scars. Br J Plast Surg 1990;43:61-9.
4. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloidal scars: a review. Plast Reconstr Surg 1999;105:1435-58.
5. Cosman B, Crikelair GF, Ju MC, Gaulin JC, Lattes R. The surgical treatment of keloidal scars. Plast Reconstr Surg 1961;27:335-58.
6. Larrabee WF Jr, East CA, Jaffe HS, Stephenson C, Peterson KE. Intralesional interferon gamma treatment for keloidal scars and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990;116:1159-62.
7. Pollack SV, Goslen JB. The surgical treatment of keloidal scars. J Dermatol Surg Oncol 1982;8:1045-9.
8. Alster TS, West TB. Treatment of scars: a review. Ann Plast Surg 1997;39:418-32.
9. Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertrophic scars and keloidal scars. Otolaryngol Clin North Am 1995;28:1057-68.
10. Brody GS. Keloids and hypertrophic scars [letter]. Plast Reconstr Surg 1990;86:804.
11. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145:105-13.
12. Tuan TL, Nichter LS. The molecular basis of hypertrophic scar formation. Mol Med Today 1998;4:19-24.
13. Marcenac N. Cheloides cicatricielles du cheval [abstract]. Recueil Med Veterinaire 1951;127:385.
14. Blackburn WR, Cosman C. Histological basis of keloid and hypertrophic scar differentiation. Clinicopathol Correlation Arch Pathol 1966;82:65-71.
15. Berman B, Flores F. The treatment of hypertrophic scars and keloidal scars. Eur J Dermatol 1998;8:591-6.
16. Boyadjiev C, Popchristova E, Mazgalova J. Histomorphic changes in keloids treated with kenacort. J Trauma 1995;38:299-302.
17. Kischer CW. Comparative ultrastructure of hypertrophic scars and keloids. Scan Electron Microsc 1984;(Pt 1):423-31.
18. Ueda K, Furuya E, Yasuda Y, Oba S, Tajima S. Keloids have continuous high metabolic activity. Plast Reconstr Surg 1999;104:694-8.
19. Nakaoka H, Miyauchi S, Miki Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Dermatol Venereol 1995;75:102-4.
20. Janssen de Limpens AM, Cormane RH. Keloidal scars and hypertrophic scars-immunological aspects. Aesthetic Plast Surg 1982;6:149-52.
21. Mathangi-Ramakrishnan K, Pothan-Thomas K, Cheyyur R. Study of 1,000 patients with keloidal scars in South India. Plast Reconstr Surg 1974;53:276-80.
22. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990;43:70-7.
23. O'Toole GA, Milward TM. Fraternal keloid. Br J Plast Surg 1999;52:408-10.
24. Matas R. The surgical peculiarities of the Negro. Tr Am Surg A 1896;14:483-5.
25. Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids. A collective review. Plast Reconstr Surg 1974;53:140-54.
26. Alhady SM, Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 1969;44:564-6.
27. Oluwasanmi JO. Keloids in the African. Clin Plast Surg 1974;1:179-95.
28. Child FJ, Fuller LC, Higgins EM, Du Vivier AW. A study of the spectrum of skin disease occurring in a black population in southeast London. Br J Dermatol 1999;141:512-7.
29. Bohrod MG. Keloidal scars and sexual selection. Arch Dermatol Syph 1937;36:19-22.
30. Hsing CT. Local reaction after BCG vaccination [abstract]. Am Rev Resp Dis 1963;88:402.
31. Inalsingh CHA. An experience in treating five hundred and one patients with keloids. Johns Hopkins Med J 1974;134:284-90.
32. Murray J. Scars and keloids. Dermatol Clin 1993;11:697-708.
33. Brown LA. Pathogenesis and treatment of pseudofolliculitis barbae. Cutis 1983;32:373-5.
34. Crutchfield CE. The causes and treatment of pseudofolliculitis barbae. Cutis 1998;61:351-6.
35. Glenn MJ, Bennett RG, Kelly AP. Acne keloidalis nuchae: treatment with excision and second-intention healing. J Am Acad Dermatol 1995;33:243-6.
36. Pestalardo CM, Cordero A Jr, Ansorena JM, Bestue M, Martinho A. Acne keloidalis nuchae. Tissue expansion treatment. Dermatol Surg 1995;21:723-4.
37. Dinehart SM, Herzberg AJ, Kerns BJ, Pollack SV. Acne keloidalis: a review. J Dermatol Surg Oncol 1989;15:642-7.
38. Sperling LC, Homoky C, Pratt L, Sau P. Acne keloidalis is a form of primary scarring alopecia. Arch Dermatol 2001;136:479-84.
39. Bergoend H, Chardon V. Spindle cell epithelioma on an old keloid of the upper extremity after a burn. Functional restoration. Ann Chir Plast 1972;17:142-44.
40. Hayrati E, Hoomand A. The keloid diathesis: a resistant state to malignancies. Plast Reconstr Surg 1977;59:555-9.
41. Anderson W. Cheloid of abdomen assuming malignant characteristics [abstract]. Lancet 1888;1:1025.
42. Crockett DJ. Regional keloid susceptibility. Br J Plast Surg 1964;17:245-53.
43. Fong EP, Chye LT, Tan WL. Keloids: time to dispel the myths? Plast Reconstr Surg 1999;104:1199-201.
44. Younai S, Nichter LS, Wellisz T, Reinisch J, Nimni ME, Tuan TL. Modulation of collagen synthesis by transforming growth factor beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994;33:148-51.
45. Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, Minor RR, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985;84:384-90.
46. Russell SR, Trupin JS, Kennedy RZ, Russel JD, Davidson JM. Glucocorticoid regulation of elastin synthesis in human fibroblasts: down regulation in fibroblasts from normal dermis but not from keloids. J Invest Dermatol 1995;105:241-5.
47. Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989;9:1642-50.
48. Kischer CW, Hendrix MJ. Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res 1983;231:29-37.
49. McCoy BJ, Cohen IK. Effects of various sera on growth kinetics and collagen synthesis by keloid and normal dermal fibroblasts. Plast Reconstr Surg 1981;67:505-10.
50. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996;98:827-33.
51. Uitto J, Perejda AJ, Abergel RP, Chu ML, Ramirez F. Altered steady state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci U S A 1985;82:5935-9.
52. Calderon M, Lawrence WT, Banes AJ. Increased proliferation of keloid fibroblasts in vitro. J Surg Res 1996;61:343-7.
53. Nakajima H, Kishi T, Tsuchiya Y, Yamada H, Tajima S. Exposure of fibroblast derived from keloid patients to low-energy electromagnetic fields: preferential inhibition of cell proliferation, collagen synthesis, and transforming growth factor beta expression in keloid fibroblasts in vitro. Ann Plast Surg 1997;39:536-41.
54. Alaish SM, Yager DR, Diegelmann RF, Cohen IK. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995;30:949-52.
55. Bertheim U, Hellstrom S. The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars. Br J Plast Surg 1994;47:483-9.
56. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT. Expression of transforming growth factor beta 1,2 and 3 proteins in keloids. Ann Plast Surg 1999;43:179-84.
57. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, et al. Activation of collagen gene expression in keloids: colocalization of type I and VI collagen and transforming growth factor beta 1 mRNA. J Invest Dermatol 1992;99:650-5.
58. Smith PD, Siegler K, Wanf X, Robson MC. Transforming growth factor beta 2 increased DNA synthesis and collagen production in keloid fibroblasts. Surg Forum 1998;49:617-9.
59. Overall CM, Wrana JL, Sodek J. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Conn Tissue Res 1989;20:289-94.
60. Smith P, Mosiello G, Deluca L, Ko F, Maggi S, Robson MC. TGF-beta2 activates proliferative scar fibroblasts. J Surg Res 1999;82:319-23.
61. Wang X, Smith P, Pu LLQ, Kim YJ, Ko F, Robson MC. Exogenous transforming growth factor β2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 1999;87:194-200.
62. Shah M, Foreman DM, Ferguson MWL. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:9851002.
63. Wu LC, Siddiqui A, Morris DE, Cox DA, Roth SI, Mustoe TA. Transforming growth factor beta-3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcriptase-polymerase chain reaction studies. Arch Surg 1997;132:753-60.
64. McCauley RL, Chopra V, Li YY, Herndon DH, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992;12:300-8.
65. Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000;89:74-7.
66. Oriente A, Fedarko NS, Pacocha SE, Huang SK, Lichtenstein LM, Essayan DM. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000;292:988-94.
67. Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 1996;149:1441-7.
68. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 1998;6:28-37.
69. Messadi DV, Le A, Berg S, Jewet A, Wen Z, Kelly P, et al. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 1999;7:511-7.
70. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-16.
71. Tuan TL, Zhu JY, Sun B, Nichter L, Nimni ME, Laug WE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996;106:1007-11.
72. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 1979;63:689-95.
73. Bloch EF, Hall MG, Denson MJ, Slay-Solomon V. General immune reactivity in keloid patients. Plast Reconstr Surg 1984;73:448-51.
74. Kischer CW, Shetlar MR, Shetlar CL, Chvapil M. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 1983;71:821-5.
75. Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 1982;13:819-24.
76. Steinbrech DS, Mehrara BJK, Chau D, Rowe NM, Chin G, Lee T, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg 1999;42:514-9.
77. Louw L, van der Westhuizen, de Wit LD, Edwards G. Keloidal scars: peripheral and central differences in cell morphologies and fatty acid compositions of lipids. In: Honn KV, Nigam S, Marnett LJ, editors. Eicosanoids and other bioactive lipids in cancer inflammation and radiation injury 2. Chapter 77. New York: Plenum Press; 1997. p. 515-20.
78. Louw L, Engelbrecht AM, Cloete F, van der Westhuizen JPJ, Dumas L. Impairment in the fatty acid composition of keloidal scars. In: Honn KV, Nigam S, Marnett LJ, editors. Eicosanoids and other bioactive lipids in cancer inflammation and radiation injury 2. Chapter 116. New York: Plenum Press; 1997. p. 905-10.
79. Cobbold CA, Sherratt JA. Mathematical modelling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring. J Theor Biol 2000;204:257-88.
80. Yagi K, Dafalla AA, Osman AA. Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitisation. Br J Plast Surg 1979;32:223-7.
81. Ehrlich HP. The physiology of wound healing. A summary of normal and abnormal wound healing processes. Adv Wound Care 1998;11:326-8.
82. Greenhalgh T. How to read a paper. Getting your bearings (deciding what a paper is about). BMJ 1997;315:243-6.
83. Rees J. Evidence-based medicine: the epistemology that isn't. J Am Acad Dermatol 2000;43:727-9.
84. Cosman B, Wolff M. Correlation of keloid recurrence with completeness of local excision: a negative report. Plast Reconstr Surg 1972;50:163-6.
85. Beausand E, Floyd H, Dunn KW, Orton CI, Ferguson MWJ. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 1998;102:1954-61.
86. Sullivan T, Smith J, Kermode J, McIver E, Courtemanche DJ. Rating the burn scar. J Burn Care Rehabil 1990;11:256-60.
87. Stern JS, Lucente FE. Carbon dioxide laser excision of earlobe keloids. A prospective study and critical analysis of existing data. Arch Otolaryngol Head Neck Surg 1989;115:1107-11.
88. Berman B, Duncan MR. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol 1989;21:694-702.
89. Wong TW, Chiu HC, Yip KM. Intralesional interferon alfa-2b has no effect in the treatment of keloids. Br J Dermatol 1994;130:683-5.
90. al-Khawajah MM. Failure of interferon alpha-2b in the treatment of mature keloids. Int J Dermatol 1996;35:515-7.
91. Conejo-Mir JS, Corbi R. Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids. J Am Acad Dermatol 1998;39:1039-40.
92. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997;37:755-7.
93. Granstein RD, Rook A, Flotte TJ, Haas A, Gallo RL, Jaffe HS, et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings. Arch Dermatol 1990;126:1295-302.
94. Pierce HE. Cryosurgery for hypertrophic scars and keloids. J Natl Med Assoc 1974:66;174-5.
95. Lortat-Jacob FJ. Traitement des cheloides par la cryotherapy. Bull soc franc dermat. Et Sylph 1931;38:979-81.
96. Shepherd JP, Dawber RP. The response of keloid scars to cryosurgery. Plast Reconstr Surg 1982;70:677-81.
97. Muti E, Ponzio E. Cryotherapy in the treatment of keloids. Ann Plast Surg 1983;11:227-32.
98. Zouboulis CC, Blume U, Buttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol 1993;129:1146-51.
99. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 1993;19:529-34.
100. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994;130:498-501.
101. Hirshowitz B, Lerner D, Moscona AR. Treatment of keloid scars by combined cryosurgery and intralesional corticosteroids. Aesthetic Plast Surg 1982;6:153-8.
102. Cirne de Castro JL, dos Santos AP, Cardoso JP, Ribeiro R. Cryosurgical treatment of a large keloid. J Dermatol Surg Oncol 1986;12:740-2.
103. Ceilley RI, Babin RW. The combined use of cryosurgery and intralesional injections of suspensions of fluorinated adrenocorticosteroids for reducing keloids and hypertrophic scars. J Dermatol Surg Oncol 1979;5:54-6.
104. Babin RW, Ceilley RI. The freeze-injection method of hypertrophic scar and keloid reduction. Otolaryngol Head Neck Surg 1979;87:911-4.
105. Tepmongkol P. Radiation therapy in the treatment of keloids. J Med Assoc Thai 1978;61:20-5.
106. Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Physiol 1989;17:77-80.
107. Doornbos JF, Stoffel TJ, Curtis-Hass A, Hussey DH, Vigliotti AP, Wen BC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Physiol 1990;18:833-9.
108. Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol 1999;72:1222-4.
109. Hoffman S. Radiotherapy for keloids [letter]. Ann Plast Surg 1982;9:265.
110. Bilbey JH, Muller NL, Miller RR, Nelemus B. Localized fibrous mesothelioma of pleura following external ionizing radiation therapy. Chest 1988;94:1291-2.
111. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992;45:374-9.
112. Ketchum LD, Smith J, Robinson DW, Masters FW. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 1966;38:209-18.
113. Griffith BH. The treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg 1966;38:202-8.
114. Griffith BH, Monroe CW, McKinney P. A follow-up study on the treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg 1970;46:145-50.
115. Kiil J. Keloids treated with topical injections of triamcinolone acetonide (Kenalog). Scand J Plast Reconstr Surg 1977;11:169-72.
116. Chowdri NA, Mattoo MMA, Darzi MA. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg 1999;69:655-9.
117. Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, Tuan R, et al. Major suppression of pro-α1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997;37:586-9.
118. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 1991;27:164-78.
119. Conway H, Gillette RW, Findley A. Differential diagnosis of keloids and hypertrophic scars by tissue culture techniques with notes on therapy of keloids by surgical excision and decadron. Plast Reconstr Surg 1960;25:117-32.
120. Scharffetter K, Wlaschek M, Hogg A, Bolsen K, Schothorst A, Goerz G, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991;283:506-11.
121. Asawanonda P, Khoo LSW, Fitzpatrick TB, Taylor CR. UV-A1 for keloid. Arch Dermatol 1999;135:348-9.
122. Hannuksela-Svahn A, Grandal OJ, Thorstensen T, Christensen OB. UVA1 for treatment of keloids [abstract]. Acta Dermatol Venereol 1999;79:490.
123. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:224-32.
124. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001;27:23-7.
125. Quinn KJ. Silicone gel in scar treatment. Burns Incl Therm Inj 1987;13:533-40.
126. Swanson JW, LeBeau JW. The effect of implantation on the physical properties of silicone rubber. J Biomed Mater Res 1974;8:357-67.
127. Quinn KG, Evans JH, Courtney JM, Gaylor JDS, Reid WH. Non-pressure treatment of hypertrophic scars. Burns Incl Therm Inj 1985;12:102-8.
128. Perkins K, Davey RB, Wallis KA. Silicone gel: a new treatment for burn scars and contractures. Burns Incl Therm Inj 1983;9:201-4.
129. Mercer NS. Silicone gel in the treatment of keloid scars. Br J Plast Surg 1989;42:83-7.
130. Gold MH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Dermatol Surg Oncol 1993;19:912-6.
131. Ohmori S. Effectiveness of silastic sheet coverage in the treatment of scar keloid (hypertrophic scar). Aesthetic Plast Surg 1988;12:95-9.
132. Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991;126:499-504.
133. Nissen FB, Spauwen PHM, Robinson PH, Fidler V, Kon M. The use of silicone occlusive sheeting (Sil-k)and silicone occlusive gel (epiderm) in the prevention of hypertrophic scar formation. Plast Reconstr Surg 1998;102:1962-72.
134. Norris JE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 1991;87:44-9.
135. Apfelberg DB, Maser MR, White DN, Lash H. Failure of carbon dioxide laser excision of keloids. Laser Surg Med 1989;9:382-8.
136. Henderson DL, Cromwell TA, Mes LG. Argon and carbon dioxide laser treatment of hypertrophic and keloid scars. Laser Surg Med 1984;3:271-7.
137. Castro DJ, Abergel RP, Meeker CA, Dwyer RM, Lesavoy MA, Uitto J. Effects of the Nd:YAG laser on DNA synthesis and collagen production in human skin fibroblast cultures. Ann Plast Surg 1983;11:214-22.
138. Abergel RP, Dwyer RM, Meeker CA, Lask G, Kelly P, Uitto J. Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser. Laser Surg Med 1984;4:291-5.
139. Sherman R, Rosenfeld H. Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg 1988;21:231-5.
140. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg 1995;21:685-7.
141. Dierickx C, Goldman MP, Fitzpatric RE. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast Reconstr Surg 1995;95:84-90.
142. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed dye-laser. Lancet 1995;345:1198-2000.
143. Alster TS. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg 1994;32:186-90.
144. Broker B. Keloid excision and recurrence prophylaxis via intradermal interferon gamma injections: a pilot study. Laryngoscopy 1996;106:1497-1501.
145. Espinassouze F, Heid E, Grosshans E. Treatment of keloid by intralesional injections of interferon alpha-2B [in French]. Ann Dermatol Venereol 1993;120:629-30.
146. Borok TL. Role of inonizing radiation for 393 keloids. Int J Radiat Oncol Biol Phys 1988;15:865-70.
147. Escarmant P, Zimmermann S, Amar A, Ratoanina JL, Moris A, Azaloux A, et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys 1993;26:245-51.
148. Clavere P, Bedane C, Bonnetblanc JM, Bonnafoux-Clavere A, Rousseau J. Postoperative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 treated scars. Dermatology 1997;195:349-52.
149. Craig RD, Pearson D. Early post operative irradiation in the treatment of keloid scars. Br J Plast Surg 1965;18:369-76.
150. Ship AG, Weiss PR, Mincer FR, Wolkstein W. Sternal keloids: successful treatment employing surgery and adjunctive radiation. Ann Plast Surg 1993;31:481-7.
151. Klumpar DI, Murray JC, Anscher M. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol 1994;31:225-31.
152. Malaker A, Ellis F, Paine CH. Keloid scars: a new method of treatment combining surgery with interstitial radiotherapy. Clin Radiol 1976;27:179-83.
153. Levy D. The role of radiation in preventing keloids. J Med Assoc State Ala 1977;47(4):50-1.
154. Dockery GL, Nilson RZ. Treatment of hypertrophic and keloid scars with SILASTIC Gel Sheeting. J Foot Ankle Surg 1994;33:110-9.
155. Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989;106:781-6.
156. Gibbons M. Experience with silastic gel sheeting in pediatric setting. J Burn Care Rehab 1994;1:69-73.
157. Katz BE. Silicone gel sheeting in scartherapy. Cutis 1995;56:65-7.
158. Jaworski S. Kenacort A treatment of hypertrophic scars and keloids in children. Pol Przegl Chir 1973;45:145-50.
159. Tang YW. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 1992;45:371-3.
160. Ratzer MA. A clinical trial of flurandrenolone tape. Br J Clin Pract 1970;24:185-9.
161. Singleton MA, Gross CW. Management of keloids by surgical excision and local injections of a steroid. South Med J 1971;64:1377-81.
162. Golladay ES. Treatment of keloids by single intraoperative perilesional injection of repository steroid. South Med J 1988;81:736-8.
163. rd. Prevention of earlobe keloid recurrence with postoperative corticosteroid indjections versus radiation therapy: a randomized, prospective study and review of literature. Dermatol Surg 1996;22:569-74.
164. Kantor GR, Wheeland RG, Bailin PL, Walker NP, Ratz JL. Treatment of earlobe keloids with carbon dioxide laser excision: a report of 16 cases. J Dermatol Surg Oncol 1985;11:1063-7.
165. Ernst K, Hundeiker M. Results of cryosurgery in 394 patients with hypertrophic scars and keloids. Hautarzt 1995;46:462-6.
166. Lindsey WH, Davis PT. Facial keloids. A 15-year experience. Arch Otolaryngol Head Neck Surg 1997;123:397-400.
167. Carney SA, Cason CG, Gowar JP, Stevenson JH, McNee J, Groves AR, et al. Cica-Care gel sheeting in the management of hypertrophic scarring. Burns 1994;20:163-7.